| Financial Year |
March 31 2023 |
| Monetary Funds |
140,888,195.37 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
278,101,176.44 |
| Advances to Suppliers |
19,014,212.90 |
| Other Receivables |
1,881,863.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
784,446,817.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,227,579.71 |
| Total Current Assets |
1,234,742,173.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,505,584,047.25 |
| Under-construction Projects |
632,602,335.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
255,576,396.29 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
36,625,116.02 |
| Deferred Income Tax Assets |
39,898,112.68 |
| Other Non-Current Assets |
63,812,142.28 |
| Sub-Total of Non-Current Assets |
2,620,057,639.89 |
| Total Assets |
3,854,799,813.05 |
| Short-Term Loans |
348,783,348.49 |
| Trading Financial liabilities |
-- |
| Notes Payable |
104,133,573.38 |
| Accounts Payable |
199,330,131.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,393,943.47 |
| Taxes Payable |
12,807,063.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,808,497.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
180,084,056.14 |
| Other Current Liabilities |
5,980,958.94 |
| Sub-Total of Current Liabilities |
868,341,425.19 |
| Long-term Loans |
1,138,054,737.70 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,142,938.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,173,989,904.10 |
| Total Liabilities |
2,042,331,329.29 |
| Paid-In Capital(Or Share Stock) |
468,000,000.00 |
| Capital Surplus |
383,625,166.68 |
| Surplus Reserve |
115,301,479.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
822,894,817.67 |
| Minority Stockholder's Interest |
11,179,582.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,801,288,901.00 |
| Owner's Equity（Stockholder's Equity） |
1,812,468,483.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,854,799,813.05 |
